Category: Press Release - Page 28 - Psychedelic Alpha

Read more about the article Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications in the US

Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications in the US

Post published:February 15, 2023
Post category:Press Release

Read more about the article Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability

Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability

Post published:February 14, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Post published:February 14, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION AND MENTAL HEALTH

FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION AND MENTAL HEALTH

Post published:February 14, 2023
Post category:Press Release

Read more about the article Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit Sponsored by Greenberg Traurig Tel Aviv

Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit Sponsored by Greenberg Traurig Tel Aviv

Post published:February 14, 2023
Post category:Press Release

Read more about the article Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s

Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s

Post published:February 13, 2023
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Post published:February 10, 2023
Post category:Press Release

Read more about the article Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Post published:February 8, 2023
Post category:Press Release

Read more about the article Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Post published:February 8, 2023
Post category:Press Release

Read more about the article Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy Therapists

Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy Therapists

Post published:February 7, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.